NO984739L - Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer - Google Patents
Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorerInfo
- Publication number
- NO984739L NO984739L NO984739A NO984739A NO984739L NO 984739 L NO984739 L NO 984739L NO 984739 A NO984739 A NO 984739A NO 984739 A NO984739 A NO 984739A NO 984739 L NO984739 L NO 984739L
- Authority
- NO
- Norway
- Prior art keywords
- cyclopent
- piperidines
- indole
- spiro
- preparation
- Prior art date
Links
- LMKPHJYTFHAGHK-UHFFFAOYSA-N cyclodrine Chemical compound C1CCCC1(O)C(C(=O)OCCN(CC)CC)C1=CC=CC=C1 LMKPHJYTFHAGHK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 125000003003 spiro group Chemical group 0.000 title abstract 3
- XVTILWLVPDMCSO-UHFFFAOYSA-N 1h-indole;piperidine Chemical class C1CCNCC1.C1=CC=C2NC=CC2=C1 XVTILWLVPDMCSO-UHFFFAOYSA-N 0.000 title 1
- 102000012440 Acetylcholinesterase Human genes 0.000 title 1
- 108010022752 Acetylcholinesterase Proteins 0.000 title 1
- 229940022698 acetylcholinesterase Drugs 0.000 title 1
- 229940082992 antihypertensives mao inhibitors Drugs 0.000 title 1
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 150000007857 hydrazones Chemical class 0.000 abstract 1
- 230000007074 memory dysfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63064196A | 1996-04-10 | 1996-04-10 | |
| PCT/US1997/003864 WO1997037992A2 (en) | 1996-04-10 | 1997-03-10 | Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984739D0 NO984739D0 (no) | 1998-10-09 |
| NO984739L true NO984739L (no) | 1998-12-09 |
Family
ID=24527997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984739A NO984739L (no) | 1996-04-10 | 1998-10-09 | Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0892802B1 (da) |
| JP (1) | JP3615225B2 (da) |
| KR (1) | KR100270145B1 (da) |
| CN (1) | CN1233249A (da) |
| AR (1) | AR006553A1 (da) |
| AT (1) | ATE252581T1 (da) |
| AU (1) | AU708124B2 (da) |
| BR (1) | BR9708563A (da) |
| CA (1) | CA2251545C (da) |
| DE (1) | DE69725713T2 (da) |
| DK (1) | DK0892802T3 (da) |
| ES (1) | ES2207718T3 (da) |
| HU (1) | HUP9902755A3 (da) |
| IL (1) | IL126003A0 (da) |
| NO (1) | NO984739L (da) |
| PT (1) | PT892802E (da) |
| WO (1) | WO1997037992A2 (da) |
| ZA (1) | ZA972984B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1604653A1 (en) | 1998-09-30 | 2005-12-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| AU2011216950A1 (en) | 2010-02-16 | 2012-08-23 | Pfizer Inc. | (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors |
| JP6790094B2 (ja) | 2015-11-12 | 2020-11-25 | エーエフエーエスシーアイ，インコーポレイテッド | イオンチャネル阻害化合物、医薬製剤および使用 |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
| WO2020048829A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 3,9-diazaspiro[5.5]undecane compounds |
-
1997
- 1997-03-01 IL IL12600397A patent/IL126003A0/xx unknown
- 1997-03-10 WO PCT/US1997/003864 patent/WO1997037992A2/en not_active Ceased
- 1997-03-10 EP EP97908068A patent/EP0892802B1/en not_active Expired - Lifetime
- 1997-03-10 DE DE69725713T patent/DE69725713T2/de not_active Expired - Fee Related
- 1997-03-10 HU HU9902755A patent/HUP9902755A3/hu unknown
- 1997-03-10 AT AT97908068T patent/ATE252581T1/de not_active IP Right Cessation
- 1997-03-10 AU AU19909/97A patent/AU708124B2/en not_active Ceased
- 1997-03-10 KR KR1019980708047A patent/KR100270145B1/ko not_active Expired - Fee Related
- 1997-03-10 DK DK97908068T patent/DK0892802T3/da active
- 1997-03-10 BR BR9708563A patent/BR9708563A/pt not_active IP Right Cessation
- 1997-03-10 JP JP53619797A patent/JP3615225B2/ja not_active Expired - Fee Related
- 1997-03-10 PT PT97908068T patent/PT892802E/pt unknown
- 1997-03-10 ES ES97908068T patent/ES2207718T3/es not_active Expired - Lifetime
- 1997-03-10 CA CA002251545A patent/CA2251545C/en not_active Expired - Fee Related
- 1997-03-10 CN CN97193690A patent/CN1233249A/zh active Pending
- 1997-04-08 ZA ZA9702984A patent/ZA972984B/xx unknown
- 1997-04-08 AR ARP970101376A patent/AR006553A1/es not_active Application Discontinuation
-
1998
- 1998-10-09 NO NO984739A patent/NO984739L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU708124B2 (en) | 1999-07-29 |
| DE69725713T2 (de) | 2004-05-13 |
| DK0892802T3 (da) | 2003-12-01 |
| WO1997037992A2 (en) | 1997-10-16 |
| ZA972984B (en) | 1997-11-03 |
| AR006553A1 (es) | 1999-09-08 |
| NO984739D0 (no) | 1998-10-09 |
| CA2251545C (en) | 2002-01-08 |
| KR20000005328A (ko) | 2000-01-25 |
| PT892802E (pt) | 2004-03-31 |
| DE69725713D1 (de) | 2003-11-27 |
| BR9708563A (pt) | 1999-08-03 |
| IL126003A0 (en) | 1999-04-11 |
| JP2002509520A (ja) | 2002-03-26 |
| HUP9902755A3 (en) | 2000-05-29 |
| ATE252581T1 (de) | 2003-11-15 |
| KR100270145B1 (ko) | 2000-11-01 |
| AU1990997A (en) | 1997-10-29 |
| EP0892802B1 (en) | 2003-10-22 |
| JP3615225B2 (ja) | 2005-02-02 |
| CN1233249A (zh) | 1999-10-27 |
| ES2207718T3 (es) | 2004-06-01 |
| CA2251545A1 (en) | 1997-10-16 |
| EP0892802A1 (en) | 1999-01-27 |
| HUP9902755A2 (hu) | 2000-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091761L (no) | Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav | |
| NO991732L (no) | Nye heterocyklylmetylsubstituerte pyrazolderivater | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| IL128003A0 (en) | Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies | |
| DK0912184T3 (da) | Anvendelse af K-252a-derivat til behandlingen af perifere eller centrale nervelidelser og cytokinoverproduktion | |
| EP0987263A3 (en) | Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| NO972910L (no) | Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister | |
| NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
| NO942618L (no) | Imidazolderivater og deres anvendelse som cytokin-inhibitorer | |
| NO991685L (no) | Anvendelse av 1-benzyl-3-(substituert hetaryl)-kondenserte pyrazolderivater for behandling av spesielle sykdommer i hjerte-kretsl°psystemet og sentralnervesystemet | |
| FI956074A0 (fi) | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia | |
| AU3508497A (en) | Androgen receptor modulator compounds and methods | |
| NO20073113L (no) | Indenylderivater og anvendelse derav for behandling av neurologiske lidelser | |
| NO975710L (no) | Nye Dolastatinderivater, deres fremstilling og anvendelse | |
| MX9707431A (es) | Inhibidores de la proteina cinasa c. | |
| EP1435945A4 (en) | TRANSDERMAL ANTIMIGRAINE THERAPY | |
| NO963850D0 (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| DK1009750T3 (da) | Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse | |
| NO985671D0 (no) | Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem | |
| DK0556332T3 (da) | Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| ZA974688B (en) | Oxime derivatives of indoles and indenes as inhibitors of prostaglandin biosynthesis. | |
| HRP20000261B1 (en) | 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides | |
| ATE315933T1 (de) | Therapeutische behandlung von kardiovaskularen krankheiten |